Atlas Trials

A Prospective Study to Evaluate the Role of T-Cell Dysfunction in Patients Who Present Symptoms Associated With Long COVID, Lyme Disease and Myalic Encephalomyelitis / Chronic Fatigue Syndrome Using the Vira Immune Fluorospot T Cell Assay

Clinical trial NCT06731179 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06731179
Sponsor
ViraxBio Labs
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Long COVIDPTLDsMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3)
Start date
2024-12-10
Primary completion
2026-06-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.